Figure 6.
Figure 6. Flow cytometric analysis of shear-induced generation of procoagulant microparticles. (A) Increased microparticle but not platelet counts in citrated whole blood flowing out of a chamber after perfusion over dVWFA1 at γw of 30 000 s–1. Flow cytometry was performed after centrifugation to PRP. Microparticles were identified by the presence of integrin αIIbβ3 (n = 5), GPIbα (n = 5), or tissue factor (TF; n = 9). Note that the microparticle counts with a positive TF signal were approximately half of the GPIb or αIIbβ3 positive ones. (B-C) Microparticle counts in citrated PRP exposed to different shear rates in a cone-and-plate viscosimeter (n = 4, respectively). Results obtained in control PRP (B) or PRP treated with cytochalasin D, which disrupts the actin cytoskeleton (C). In either case, the increase in microparticle generation was significant when γw of 10 000 s–1. Note that the increase of microparticle counts in the cytochalasin D–treated PRP was approximately half that seen in control PRP. The counts reported in panels A to C are for events acquired over a 1-minute period (A) or a 3-minute period (B-C). (D) Clotting time obtained after addition of calcium ions (25 mM) and tissue factor (1.44 ng/mL) to PRP exposed to different shear rates (n = 8). A significant reduction was observed in PRP exposed to a shear rate of 10 000 s–1. (E) Significant reduction of the clotting time obtained after addition of calcium but not tissue factor to PRP exposed to the shear rate of 10 000 s–1 (n = 3). PGE1, apyrase, tirofiban, and CTI were present in the PRP. (F) Change in the number of microparticles positive for αIIbβ3 (CD41) or phosphatidylserine, measured by annexin (anx) V binding, after exposure of PRP to a shear rate of 10 000 s–1 (n = 5). The detected increase was more pronounced when the flow cytometric analysis after shearing was performed in PPP as compared with PRP. All results are shown as mean ± SEM. ***P < .01; **P < .05.

Flow cytometric analysis of shear-induced generation of procoagulant microparticles. (A) Increased microparticle but not platelet counts in citrated whole blood flowing out of a chamber after perfusion over dVWFA1 at γw of 30 000 s–1. Flow cytometry was performed after centrifugation to PRP. Microparticles were identified by the presence of integrin αIIbβ3 (n = 5), GPIbα (n = 5), or tissue factor (TF; n = 9). Note that the microparticle counts with a positive TF signal were approximately half of the GPIb or αIIbβ3 positive ones. (B-C) Microparticle counts in citrated PRP exposed to different shear rates in a cone-and-plate viscosimeter (n = 4, respectively). Results obtained in control PRP (B) or PRP treated with cytochalasin D, which disrupts the actin cytoskeleton (C). In either case, the increase in microparticle generation was significant when γw of 10 000 s–1. Note that the increase of microparticle counts in the cytochalasin D–treated PRP was approximately half that seen in control PRP. The counts reported in panels A to C are for events acquired over a 1-minute period (A) or a 3-minute period (B-C). (D) Clotting time obtained after addition of calcium ions (25 mM) and tissue factor (1.44 ng/mL) to PRP exposed to different shear rates (n = 8). A significant reduction was observed in PRP exposed to a shear rate of 10 000 s–1. (E) Significant reduction of the clotting time obtained after addition of calcium but not tissue factor to PRP exposed to the shear rate of 10 000 s–1 (n = 3). PGE1, apyrase, tirofiban, and CTI were present in the PRP. (F) Change in the number of microparticles positive for αIIbβ3 (CD41) or phosphatidylserine, measured by annexin (anx) V binding, after exposure of PRP to a shear rate of 10 000 s–1 (n = 5). The detected increase was more pronounced when the flow cytometric analysis after shearing was performed in PPP as compared with PRP. All results are shown as mean ± SEM. ***P < .01; **P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal